Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast epithelial mucin serum clearance.

R L Ceriani1, E W Blank

  • 1John Muir Cancer and Aging Research Institute, Walnut Creek, CA 94596.

Cancer Letters
|June 14, 1991
PubMed
Summary

Serum breast cancer marker levels, like breast epithelial mucin, often don't correlate with tumor size. This study reveals significant tumor load and release are needed to overcome clearance, impacting breast cancer detection accuracy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and functional aspects of three major glycoproteins of the human milk fat globule membrane.

Advances in experimental medicine and biology·2002
Same author

Protective function of human milk: the milk fat globule.

Seminars in perinatology·1999
Same author

Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.

Hybridoma·1999
Same author

Milk fat globule glycoproteins in human milk and in gastric aspirates of mother's milk-fed preterm infants.

Pediatric research·1998
Same author

Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·1998
Same author

Role of human-milk lactadherin in protection against symptomatic rotavirus infection.

Lancet (London, England)·1998

Area of Science:

  • Oncology
  • Biochemistry
  • Immunology

Background:

  • Breast epithelial mucin is a serum marker for breast cancer detection.
  • Current immunoassays show poor correlation with tumor load and frequent false negatives in breast cancer relapse.
  • The reasons for these limitations in breast cancer marker assays require further investigation.

Purpose of the Study:

  • To investigate the causes for the poor correlation between serum breast epithelial mucin levels and breast tumor load.
  • To understand the factors influencing the reliability of breast epithelial mucin as a breast cancer marker.
  • To elucidate the clearance mechanisms affecting serum breast cancer marker levels.

Main Methods:

  • Utilized immunodeficient mice xenografted with human breast tumors.
  • Administered radioimmunotherapy to induce high marker release.
  • Induced hepatic toxicity using carbon tetrachloride to probe clearance pathways.

Main Results:

  • Elevated serum breast epithelial mucin was observed only after a significant tumor load threshold was reached.
  • Highly increased marker release, induced by radioimmunotherapy, was necessary to overcome clearance.
  • Carbon tetrachloride-induced hepatic toxicity demonstrated a hepatic clearance mechanism for breast epithelial mucin.

Conclusions:

  • Serum breast epithelial mucin levels are influenced by tumor load and marker release rates.
  • Hepatic clearance significantly impacts the detectability of breast epithelial mucin in serum.
  • Current limitations in breast cancer marker assays may stem from insufficient marker release and efficient clearance mechanisms.

Related Experiment Videos